SMC approval welcome news for breast cancer patients
Pharma Times
MARCH 9, 2022
Trodelvy is accepted for use in mTNBC patients who have already received two or more systemic therapies
patients news 
#news #biotech Biomarker identifies high-risk COVID-19 patients
BioTech 365
FEBRUARY 23, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biomarker identifies high-risk COVID-19 patients. from European Biotechnology – first and foremost in European biotech [link].
Research 
40
40 Research 40
40 Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
#news #biotech Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
BioTech 365
DECEMBER 21, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment.Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment aarmstrong Tue, 12/21/2021 – … Continue (..)
Gene Therapy 40
40 
#news #biotech Gerngross’ Adagio starts testing antibody in COVID-19 patients
BioTech 365
APRIL 13, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gerngross’ Adagio starts testing antibody in COVID-19 patients.Gerngross’ Adagio starts testing antibody in COVID-19 patients ntaylor Tue, 04/13/2021 – 09:01 from FierceBiotech: Biotech [link].
Antibody 40
40 
Cognitive decline in early Alzheimer’s could stem from serotonin loss
Pharma Times
DECEMBER 18, 2023
MCI patients had 25% lower levels of serotonin compared to healthy patients - News - PharmaTimes
140 
#news #biotech Tmunity stops solid tumor CAR-T trial after 2 patients die
BioTech 365
JUNE 3, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Tmunity stops solid tumor CAR-T trial after 2 patients die.Tmunity stops solid tumor CAR-T trial after 2 patients die ntaylor Thu, 06/03/2021 – 08:18 from FierceBiotech: Biotech … Continue reading →
Trials 40
40 
UniQure moves Huntington's gene therapy to next phase of key trial
Bio Pharma Dive
MAY 27, 2021
Safety monitors cleared the company to test a higher dose after reviewing data from 10 patients, providing some hopeful news after recent setbacks for experimental drugs targeting the genetic disease.
Gene Therapy 304
304 
#news #biotech RedHill posts data in COVID-19 patients on supplemental oxygen
BioTech 365
JANUARY 4, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: RedHill posts data in COVID-19 patients on supplemental oxygen.RedHill posts data in COVID-19 patients on supplemental oxygen ntaylor Mon, 01/04/2021 – 07:25 from FierceBiotech: Biotech [link].
Research 40
40 Research 40
40 
#news #biotech FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death
BioTech 365
NOVEMBER 24, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death.FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death … Continue reading →
Trials 40
40 
#news #biotech FDA calls for more terminal patients to be included in cancer trials
BioTech 365
JUNE 25, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FDA calls for more terminal patients to be included in cancer trials.FDA calls for more terminal patients to be included in cancer trials badams Fri, 06/25/2021 – … Continue reading →
Trials 40
40 
#news #biotech Drug set to rescue COVID-19 patients at ICUs
BioTech 365
NOVEMBER 26, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Drug set to rescue COVID-19 patients at ICUs. from European Biotechnology – first and foremost in European biotech [link].
Drugs 40
40 
#news #biotech VCs back Leucid to trial CAR-T twist in ovarian cancer patients
BioTech 365
OCTOBER 21, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: VCs back Leucid to trial CAR-T twist in ovarian cancer patients.VCs back Leucid to trial CAR-T twist in ovarian cancer patients ntaylor Thu, 10/21/2021 – 08:09 from … Continue reading →
Trials 40
40 
#news #biotech Ultragenyx pauses antisense trial after patients lose ability to walk
BioTech 365
OCTOBER 27, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ultragenyx pauses antisense trial after patients lose ability to walk.Ultragenyx pauses antisense trial after patients lose ability to walk ntaylor Tue, 10/27/2020 – 07:26 from FierceBiotech: Biotech … Continue reading (..)
Trials 40
40 
Study: Bad medical news causes patients to choose brand name drugs over generics, costing billions
Medical Xpress
APRIL 19, 2023
Researchers from Johns Hopkins University published a new Journal of Marketing article that examines how receiving negative medical results might affect how people choose between generic and brand name drugs.
Branding 95
95 
#news #biotech MGH team shows how injured muscles might be repaired with patients’ own skin cells
BioTech 365
AUGUST 20, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: MGH team shows how injured muscles might be repaired with patients’ own skin cells.MGH team shows how injured muscles might be repaired with patients’ own skin cells … Continue reading →
Research 40
40 Research 40
40 
#news #biotech Lilly’s COVID-19 antibody fails trial in hospitalized patients
BioTech 365
OCTOBER 27, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s COVID-19 antibody fails trial in hospitalized patients.Lilly’s COVID-19 antibody fails trial in hospitalized patients ntaylor Tue, 10/27/2020 – 06:31 from FierceBiotech: Biotech [link].
Antibody 40
40 
#news #biotech Bluebird stops gene therapy trials after 2 sickle cell patients develop cancer
BioTech 365
FEBRUARY 16, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bluebird stops gene therapy trials after 2 sickle cell patients develop cancer.Bluebird stops gene therapy trials after 2 sickle cell patients develop cancer ntaylor Tue, 02/16/2021 – … Continue reading →
Gene Therapy 40
40 
#news #biotech Avrobio tracks improvements in first patient treated with Gaucher gene therapy
BioTech 365
NOVEMBER 17, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Avrobio tracks improvements in first patient treated with Gaucher gene therapy.Avrobio tracks improvements in first patient treated with Gaucher gene therapy ntaylor Tue, 11/17/2020 – 08:08 from … Continue reading → (..)
Gene Therapy 40
40 
Neuroplast spinal cord injury study milestone
Pharma Times
SEPTEMBER 7, 2023
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries - News - PharmaTimes
Trials 159
159 Trials 159
159 
#news #biotech Ride Health gives patients a lift to COVID-19 treatment, vaccine trials
BioTech 365
JANUARY 20, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ride Health gives patients a lift to COVID-19 treatment, vaccine trials.Ride Health gives patients a lift to COVID-19 treatment, vaccine trials chale Wed, 01/20/2021 – 09:16 from … Continue reading →
Vaccination 40
40 #news #biotech Humanigen links drug to improvements in severe COVID-19 patients
BioTech 365
NOVEMBER 6, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Humanigen links drug to improvements in severe COVID-19 patients.Humanigen links drug to improvements in severe COVID-19 patients ntaylor Fri, 11/06/2020 – 08:04 from FierceBiotech: Biotech [link].
Drugs 40
40 
Samay’s AI-assisted wearable technology accurately diagnoses COPD
Pharma Times
NOVEMBER 6, 2023
The device successfully diagnosed COPD in patients with 90% accuracy - News - PharmaTimes
159 
#news #biotech Convalescent plasma fails phase 2 in moderate COVID-19 patients
BioTech 365
OCTOBER 23, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Convalescent plasma fails phase 2 in moderate COVID-19 patients.Convalescent plasma fails phase 2 in moderate COVID-19 patients ntaylor Fri, 10/23/2020 – 05:27 from FierceBiotech: Biotech [link].
Research 40
40 Research 40
40 
October 5, 2023: GRACE Trial Featured on CBS News Chicago for Sickle Cell Awareness Month
Rethinking Clinical Trials
OCTOBER 5, 2023
The GRACE trial, an NIH Pragmatic Trials Collaboratory Demonstration Project, was featured in a segment on CBS News Chicago. Co–principal investigator Ardith Doorenbos was interviewed for the segment as part of the news program’s observance of Sickle Cell Awareness Month. ” View the full news segment. .
Trials 141
141 
#news #biotech RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients
BioTech 365
SEPTEMBER 14, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients.RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients badams Tue, … Continue reading → (..)
Drugs 40
40 
#news #biotech NIH stops trial of Brii’s COVID-19 antibodies in hospitalized patients for futility
BioTech 365
MARCH 5, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: NIH stops trial of Brii’s COVID-19 antibodies in hospitalized patients for futility.NIH stops trial of Brii’s COVID-19 antibodies in hospitalized patients for futility ntaylor Fri, 03/05/2021 – … Continue (..)
Antibody 40
40 
Cambridge researchers redesign future mRNA therapeutics
Pharma Times
DECEMBER 8, 2023
One-third of patients who received Pfizer’s COVID-19 vaccine had unintended immune responses - News - PharmaTimes
Immune Response 136
136 #news #biotech AHA: Bayer’s finerenone helps kidney, heart disease patients regardless of medical history
BioTech 365
NOVEMBER 16, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AHA: Bayer’s finerenone helps kidney, heart disease patients regardless of medical history.AHA: Bayer’s finerenone helps kidney, heart disease patients regardless of medical history chale Sun, 11/15/2020 – … (..)
Research 40
40 Research 40
40 
#news #biotech Translate Bio’s mRNA fails to improve lung function in cystic fibrosis patients
BioTech 365
MARCH 18, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Translate Bio’s mRNA fails to improve lung function in cystic fibrosis patients.Translate Bio’s mRNA fails to improve lung function in cystic fibrosis patients ntaylor Thu, 03/18/2021 – … Continue reading (..)
Research 40
40 Research 40
40 
Digital health collaboration to trial AI-powered X-rays for lung cancer detection
Pharma Times
DECEMBER 18, 2023
Earlier diagnosis could increase patient survival rates by five years or more - News - PharmaTimes
Trials 137
137 Trials 137
137 
#news #biotech Adverum shares halved after trial patient goes blind in one eye after experimental gene therapy
BioTech 365
APRIL 29, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Adverum shares halved after trial patient goes blind in one eye after experimental gene therapy.Adverum shares halved after trial patient goes blind in one eye after experimental … Continue reading →
Gene 40
40 
#news #biotech Asking the right questions, recruiting the right patients: AI in clinical trials
BioTech 365
SEPTEMBER 2, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Asking the right questions, recruiting the right patients: AI in clinical trials.Asking the right questions, recruiting the right patients: AI in clinical trials aalidrus Fri, 08/28/2020 – … Continue reading → (..)
COVID-19: Dire Predictions from WHO and Good News for Older Patients
BioSpace
NOVEMBER 23, 2021
Although vaccines and effective therapeutics are powerful tools in preventing and treating COVID-19, we’re not done battling the disease just yet. For those stories and more, read on.
Vaccination 98
98 
#news #biotech AstraZeneca targets severe COVID-19 patients for antibody therapy despite Regeneron, Lilly setbacks
BioTech 365
NOVEMBER 6, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca targets severe COVID-19 patients for antibody therapy despite Regeneron, Lilly setbacks.AstraZeneca targets severe COVID-19 patients for antibody therapy despite Regeneron, Lilly setbacks ntaylor Fri, 11/06/2020 – (..)
Antibody 40
40 
NHS patients to be offered the opportunity to travel for treatment
Pharma Times
OCTOBER 31, 2023
Around 400,000 eligible patients are set to benefit from the travel offer - News - PharmaTimes
149 
NICE nod for Darzalex with lenalidomide and dexamethasone
Pharma Times
SEPTEMBER 25, 2023
Therapy has been developed to treat adult patients with newly diagnosed multiple myeloma - News - PharmaTimes
Development 149
149 Development 149
149 
NHS virtual wards to treat heart failure patients at home
Pharma Times
OCTOBER 26, 2023
Thousands of patients with heart failure are set to benefit from the expansion - News - PharmaTimes
147 
Clinical News: MDMA and Therapy Significantly Benefits PTSD Patients and More
BioSpace
MAY 4, 2021
BioSpace takes a look at data released this week from some of the numerous ongoing clinical studies to advance potential therapies and treatment for disease. Here are some of them.
98 
DigitalHealth.London’s Accelerator programme selects Aide
Pharma Times
JULY 3, 2023
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes
157 
#news #biotech Novartis targets Alexion’s fiefdom after showing PNH patients can safely switch from Soliris
BioTech 365
AUGUST 31, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novartis targets Alexion’s fiefdom after showing PNH patients can safely switch from Soliris.Novartis targets Alexion’s fiefdom after showing PNH patients can safely switch from Soliris ntaylor Mon, … Continue (..)
Research 40
40 Research 40
40 
MHRA launches online eligibility checker tool via the IRP
Pharma Times
NOVEMBER 27, 2023
The IRP will bring life-saving medicines to UK patients from 1 January 2024 - News - PharmaTimes
Medicine 139
139 Medicine 139
139 #news #biotech CRISPR, Vertex show CRISPR/Cas9 gene-editing therapy works in more patients
BioTech 365
NOVEMBER 5, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CRISPR, Vertex show CRISPR/Cas9 gene-editing therapy works in more patients.CRISPR, Vertex show CRISPR/Cas9 gene-editing therapy works in more patients ntaylor Thu, 11/05/2020 – 08:52 from FierceBiotech: Biotech … Continue (..)
Gene Editing 40
40 
Fewer MS patients are prescribed DMTs in UK compared to Europe
Pharma Times
OCTOBER 2, 2023
The study analysed and compared information from 65,000 MS patients - News - PharmaTimes
150 #news #biotech After COVID flop, Angion’s leading med fails again, this time in kidney transplant patients as shares halved
BioTech 365
OCTOBER 27, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After COVID flop, Angion’s leading med fails again, this time in kidney transplant patients as shares halved.After COVID flop, Angion’s leading med fails again, this time in … Continue reading →
Research 40
40 Research 40
40 
Let's personalize your content